Searched for
PONTA SAHIB
Himachal elections: Congress declares four more candidatesNigam Bhandari, the leader of the Himachal Youth Congress, filed for nomination from Kinnaur. Bhuvneshwar Gaur was the candidate for the Ma...- Dharamsala to have a Hollywood-style hillside signDharamsala will have a sign on the lines of the famous 'Hollywood' sign in Los Angeles, on a hillock of Indru Nag.
- Tiger census: The big cats are back, now clear their corridorsIndian tigers have come roaring back to life from the crisis of 2006, when just 1,411 were found to be left in the wild.
- The big cats are back, now clear their corridorsA recent study has tiger conservationists gearing up for a new battle to protect vital forest links from development.
- USFDA ban on Toansa plant disappointing: RanbaxyTerming the USFDA ban on its Toansa plant 'disappointing', Ranbaxy Laboaratories today said it will take 'appropriate management action' fo...
- Ranbaxy Labs rallies 60% since August, loses 35% in a day thanks to FDA: Time to book profits?Analysts at top brokerage firms have turned cautious on Ranbaxy after reports that the FDA has issued an import alert on the Mohali unit.
- St hammers Sun Pharma as USFDA seizes 33 drugs of armUS authorities seized drugs made by Sun Pharmaceuticals’ US subsidiary for violation of manufacturing standards, pushing down share prices ...
- Investors at risk as US FDA gets tough with drug cosRecent warning letters issued by US Food and Drug Administration, to manufacturing units of Indian pharmaceutical companies, have significa...
- Foreign brokerages downgrade RanbaxyForeign brokerages have downgraded Ranbaxy Laboratories after the US FDA (Food and Drug Administration) recently invoked its Application In...
- Ranbaxy falls 6 pc in weak marketShares of domestic pharma major Ranbaxy Laboratories today touched a 52-week low of Rs 250.50 with analysts saying that it is the effect of...
- Ranbaxy plans Rs 200-cr dosage facilityRanbaxy is planning to set up a new dosage manufacturing facility to cater to the emerging and non-regulated markets.
- Ranbaxy plans Rs 200-cr dosage facilitymaker Ranbaxy is planning to set up a new dosage manufacturing facility to cater to the emerging and non-regulated markets.
- Ranbaxy may locate new unit in MohaliIndia’s largest drug maker Ranbaxy is planning to set up a new dosage manufacturing facility to cater to the emerging and non-regulated mar...
- Ranbaxy plans Rs 200 cr dosage facilityThe company is expected to invest a “couple of hundred crores” in the high capacity plant that will be developed in two phases, a Ranbaxy i...
- After BPO, pharma faces US backlashUS drug makers are accusing India of being a source of low-quality exports & are exerting pressure on USFDA.
Load More- The big cats are back, now clear their corridors
